Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Indices Open Flat
Wed, 22 Jun 09:30 am

Major Asian stock markets have opened the day on a positive note with stock markets in Singapore and China are trading higher by 0.7% and 0.4% respectively. Benchmark indices in Europe and US ended their previous session in green with stock markets in Germany ending the day higher by 0.6%. The rupee is trading at 67.47 per US$.

Indian stock markets have opened the day on a flattish note. The BSE Sensex is trading marginally higher by 12 points (up 0.05%) and the NSE Nifty is trading higher by 3 points (up 0.04%). However, BSE Mid Cap and BSE Small Cap are trading higher by 0.2% and 0.3% respectively.

Major sectoral indices have opened the day on a positive note with stocks from realty and pharmaceutical sector are witnessing buying interest.

As per an article in Livemint, government on Monday opened up the automatic route in the pharma sector for attracting foreign direct investment (FDI).

As per the new provisions, government has decided to increase FDI limits to 74% in existing pharmaceutical companies through the automatic route. Earlier, 100% FDI was permitted through the government approval route.

The government approval route was a cumbersome process wherein there was uncertainty whether the deal would be approved or not.

Opening up of the automatic route is expected to boost mergers & acquisitions (M&A) and private equity investment in the sector in future. India is known for its low production cost owing to its cheap labour. While, selling products in the US, the Indian companies earn high margins. This is one of the factors which would attract investments in the pharma sector.

Reportedly, the move is also expected to stimulate more investments in the CRAMS segment (Contract Research and Manufacturing Service). Increased M&A deals will help unlock potential value of the existing companies in pharma space and could possibly add to the shareholders wealth.

In another news update, India continued to be among the top ten countries in terms of foreign direct investment (FDI) inflows globally. Moreover, it ranked fourth in the same amongst the Asian economies.

The FDI inflows have increased by 25% YoY to US$ 44 billion in the fiscal year 2015. Reportedly, the surge is mainly on account of the Make in India initiative, alongside liberalization measures and reforms initiated by the government.

In the past few days the government opened the doors wider on the foreign direct investment (FDI) front. The government has increased the cap in FDI in seven sectors ranging from civil aviation and defence to food products and pharmaceutical. This too will increase the FDI flows going forward. Increased foreign investments would help boost the economic growth as well as create employment opportunities in the country.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian Indices Open Flat". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jan 23, 2018 09:41 AM